Results 41 to 50 of about 1,849 (135)

Three-year dynamics and unsolved problems of lipid-lowering therapy

Рациональная фармакотерапия в кардиологии, 2015
Aim. To study the lipid-lowering therapy, the adequacy of its control, as well as the awareness of patients at a high cardiovascular risk of atherosclerosis problems and the dynamics of these parameters in 3 years. Material and methods.
V. A. Sergeeva
doaj   +1 more source

Атеросклероз и артериальная гипертензия две болезни – одна стратегия [PDF]

, 2011
Изложены эпидемиология, факторы риска, этиология, механизмы, клиника, лечение, прогноз атеросклероза и артериальной гипертензии в современном понимании.
Макиенко, Н.В., Яблучанский, Н.И.   +1 more
core  

THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION

Рациональная фармакотерапия в кардиологии, 2015
Review of large of trials that prove the positive impact of high-dose lipid-lowering therapy on the prognosis in patients with ischemic heart disease (IHD) are presented.
R. N. Adzhiev, M. S. Safarova, M. V. Ezhov   +2 more
doaj   +1 more source

Pharmacoepidemiological analysis of the drugs used for secondary prevention of brain infarction on dispensary stage [PDF]

, 2014
Aim. The secondary prevention of cerebral infarction on dispensary stage to current clinical guidelines was analyzed. Adherence of patients to prescribe medications was evaluated. Material and methods.
Furman N.V., Miheyeva N.V., Reshetko O.V.   +2 more
core  

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN

Рациональная фармакотерапия в кардиологии, 2015
The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction and other cardiovascular events in patients with percutaneous coronary intervention is discussed.
N. G. Gogolashvili
doaj   +1 more source

Кокрановские обзоры как информационный ресурс доказательной первичной профилактики в здравоохранении [PDF]

, 2013
ЗДРАВООХРАНЕНИЕИНФОРМАЦИОННЫЕ СИСТЕМЫкокрановские обзорыПРОФИЛАКТИЧЕСКАЯ ...
Пузанова, О. Г.
core  

Метод оценки вероятности сопряженности транспорта аторвастатина и его метаболически активных дериватов с липопротеинами низкой и очень низкой плотности [PDF]

, 2015
аторвастатинЛИПОПРОТЕИНЫХОЛЕСТЕРИНстатиныкровьальбуминишемическая болезнь ...
Осочук, С. С., Буянова, С. В., Марцинкевич, А. Ф.   +2 more
core   +1 more source

The specific treatment of dyslipidemia in patients with diabetes type 2

Медицинский совет, 2016
The review tells about the specific diagnosis and treatment of dyslipidemia in patients with diabetes type 2 aimed at preventing serious cardiovascular complications.
S. A. Urazgildeeva, O. F. Malygina
doaj   +1 more source

Влияние статинов на гормональный спектр крови и содержание холестерола в надпочечниках белых лабораторных крыс [PDF]

, 2014
КРОВЬГОРМОНЫХОЛЕСТЕРИНстатиныНАДПОЧЕЧНИКИЭКСПЕРИМЕНТЫ НА ...
Буянова, С. В., Осочук, С. С.   +1 more
core  

Effect of statins on LDL cholesterol and lower risk of cardiovascular complications. Which medication to choose?

Медицинский совет, 2016
Primary and secondary prevention of cardiovascular complications (CVC) has been one of the key areas in modern cardiology over the past decades. The article examined the relationship between the risk of CVC and the lipid metabolism parameters.
N. M. Savina, B. A. Sidorenko
doaj   +1 more source